{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:50:22Z","timestamp":1791240622153,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201908500113"],"award-info":[{"award-number":["201908500113"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jcrc.2023.154395","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T18:21:57Z","timestamp":1691086917000},"page":"154395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Population pharmacokinetics of dexamethasone in critically ill COVID-19 patients: Does inflammation play a role?"],"prefix":"10.1016","volume":"78","author":[{"given":"Letao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan","family":"Sassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Hunfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Smeets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Ewoldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd A.A.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit C.P.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Endeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2023.154395_bb0005","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/S0140-6736(22)00484-6","article-title":"Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis","volume":"399","author":"Collaborators","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jcrc.2023.154395_bb0010","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(21)02796-3","article-title":"Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21","volume":"399","author":"Collaborators","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jcrc.2023.154395_bb0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/CCM.0000000000005185","article-title":"Trends in ICU mortality from coronavirus disease 2019: a tale of three surges","volume":"50","author":"Auld","year":"2022","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.jcrc.2023.154395_bb0020","doi-asserted-by":"crossref","first-page":"00554","DOI":"10.1183\/23120541.00554-2022","article-title":"Moderate to severe ARDS: COVID-19 patients compared to influenza patients for ventilator parameters and mortality","volume":"9","author":"Maamar","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jcrc.2023.154395_bb0025","doi-asserted-by":"crossref","first-page":"316","DOI":"10.7150\/thno.49713","article-title":"Immunopathogenesis and treatment of cytokine storm in COVID-19","volume":"11","author":"Kim","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jcrc.2023.154395_bb0030","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0140-6736(21)00439-6","article-title":"Acute respiratory distress syndrome","volume":"398","author":"Meyer","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jcrc.2023.154395_bb0035","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41577-020-00421-x","article-title":"After 62 years of regulating immunity, dexamethasone meets COVID-19","volume":"20","author":"Cain","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcrc.2023.154395_bb0040","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Group, R.C","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2023.154395_bb0045","article-title":"Severe covid-19 pneumonia: pathogenesis and clinical management","volume":"372","author":"Attaway","year":"2021","journal-title":"Bmj"},{"key":"10.1016\/j.jcrc.2023.154395_bb0050","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(11)60607-7","article-title":"Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Meijvis","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jcrc.2023.154395_bb0055","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1001\/jama.2021.18295","article-title":"Effect of 12 mg vs 6 mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID STEROID 2 randomized trial","volume":"326","author":"Group, C.S.T","year":"2021","journal-title":"Jama"},{"key":"10.1016\/j.jcrc.2023.154395_bb0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0960-0760(97)00038-1","article-title":"Dexamethasone metabolism in vitro: species differences","volume":"62","author":"Tomlinson","year":"1997","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jcrc.2023.154395_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.814134","article-title":"PBPK modelling of dexamethasone in patients with COVID-19 and liver disease","volume":"13","author":"Montanha","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcrc.2023.154395_bb0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40262-023-01213-x","article-title":"Pharmacokinetic alterations associated with critical illness","volume":"62","author":"Morales Castro","year":"2023","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jcrc.2023.154395_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.733935","article-title":"Influence of inflammation on cytochromes P450 activity in adults: a systematic review of the literature","volume":"12","author":"Lenoir","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcrc.2023.154395_bb0080","doi-asserted-by":"crossref","first-page":"871","DOI":"10.31557\/APJCP.2021.22.3.871","article-title":"Pharmacokinetics of dexamethasone when administered with Fosaprepitant for chemotherapy-induced nausea and vomiting and differences in dose-dependent antiemetic effects","volume":"22","author":"Shimamoto","year":"2021","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.jcrc.2023.154395_bb0085","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/bcp.12295","article-title":"Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-acquired pneumonia","volume":"78","author":"Spoorenberg","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jcrc.2023.154395_bb0090","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.clml.2020.06.022","article-title":"Comparative safety, bioavailability, and pharmacokinetics of Oral dexamethasone, 4-mg and 20-mg tablets, in healthy volunteers under fasting and fed conditions: a randomized open-label, 3-way crossover study","volume":"20","author":"Bashir","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jcrc.2023.154395_bb0095","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.clinthera.2011.10.006","article-title":"Pharmacokinetics, pharmacodynamics, and comparative bioavailability of single, oral 2-mg doses of dexamethasone liquid and tablet formulations: a randomized, controlled, crossover study in healthy adult volunteers","volume":"33","author":"Queckenberg","year":"2011","journal-title":"Clin Ther"},{"key":"10.1016\/j.jcrc.2023.154395_bb0100","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/cts.12724","article-title":"Pharmacokinetics and pharmacodynamics of intramuscular and Oral betamethasone and dexamethasone in reproductive age women in India","volume":"13","author":"Jobe","year":"2020","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jcrc.2023.154395_bb0105","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1007\/s40121-021-00500-z","article-title":"Potential adverse effects of dexamethasone therapy on COVID-19 patients: review and recommendations","volume":"10","author":"Chen","year":"2021","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jcrc.2023.154395_bb0110","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13054-022-04049-2","article-title":"Impact of dexamethasone on the incidence of ventilator-associated pneumonia in mechanically ventilated COVID-19 patients: a propensity-matched cohort study","volume":"26","author":"Scaravilli","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2023.154395_bb0115","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s13054-022-04170-2","article-title":"Relationship between corticosteroid use and incidence of ventilator-associated pneumonia in COVID-19 patients: a retrospective multicenter study","volume":"26","author":"Saura","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2023.154395_bb0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s43440-021-00341-0","article-title":"Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial","volume":"74","author":"Toroghi","year":"2022","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.jcrc.2023.154395_bb0125","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1378\/chest.11-1396","article-title":"Introduction to drug pharmacokinetics in the critically ill patient","volume":"141","author":"Smith","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jcrc.2023.154395_bb0130","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1208\/s12248-012-9407-9","article-title":"Shrinkage in nonlinear mixed-effects population models: quantification, influencing factors, and impact","volume":"14","author":"Xu","year":"2012","journal-title":"AAPS J"},{"key":"10.1016\/j.jcrc.2023.154395_bb0135","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1128\/AAC.02004-15","article-title":"Population pharmacokinetics of pyronaridine in pediatric malaria patients","volume":"60","author":"Ayyoub","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcrc.2023.154395_bb0140","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s11095-010-0333-1","article-title":"Systematic evaluation of the descriptive and predictive performance of paediatric morphine population models","volume":"28","author":"Krekels","year":"2011","journal-title":"Pharm Res"},{"key":"10.1016\/j.jcrc.2023.154395_bb0145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","article-title":"Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models","volume":"13","author":"Bergstrand","year":"2011","journal-title":"AAPS J"},{"key":"10.1016\/j.jcrc.2023.154395_bb0150","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/00912700122010285","article-title":"Pharmacokinetics and pharmacodynamics of dexamethasone sodium-m-sulfobenzoate (DS) after intravenous and intramuscular administration: a comparison with dexamethasone phosphate (DP)","volume":"41","author":"Hochhaus","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jcrc.2023.154395_bb0155","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1530\/EJE-21-0395","article-title":"Rationale of a lower dexamethasone dose in prenatal congenital adrenal hyperplasia therapy based on pharmacokinetic modelling","volume":"185","author":"Stachanow","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcrc.2023.154395_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010105","article-title":"Pharmacokinetic study of intranasal dexamethasone and methylprednisolone compared with intravenous administration: two open-label, single-dose, two-period, two-sequence, cross-over study in healthy volunteers","volume":"15","author":"C\u00e1rdenas","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jcrc.2023.154395_bb0165","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/00007691-199910000-00007","article-title":"Pharmacokinetics of high-dose oral and intravenous dexamethasone","volume":"21","author":"T\u00f3th","year":"1999","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jcrc.2023.154395_bb0170","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/bdd.2510080302","article-title":"Pharmacokinetics of dexamethasone and its phosphate ester","volume":"8","author":"Rohdewald","year":"1987","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.jcrc.2023.154395_bb0175","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1124\/jpet.122.001477","article-title":"Pharmacokinetic\/pharmacodynamic modeling of dexamethasone anti-inflammatory and immunomodulatory effects in LPS-challenged rats: a model for cytokine release syndrome","volume":"384","author":"\u015awierczek","year":"2023","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jcrc.2023.154395_bb0180","first-page":"1","article-title":"Is dexamethasone a substrate, an inducer, or a substrate-inducer of CYP3As","volume":"2","author":"Al Rihani","year":"2020","journal-title":"Arch Phar Pharmacol Res"},{"key":"10.1016\/j.jcrc.2023.154395_bb0185","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40560-021-00580-6","article-title":"Effects of dexamethasone on immune dysfunction and ventilator-associated pneumonia in COVID-19 acute respiratory distress syndrome: an observational study","volume":"9","author":"Cour","year":"2021","journal-title":"J Intensive Care"},{"key":"10.1016\/j.jcrc.2023.154395_bb0190","article-title":"Clinical features of COVID-19 patients with rebound phenomenon after corticosteroid therapy","volume":"9","author":"Murakami","year":"2022","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.jcrc.2023.154395_bb0195","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1128\/AAC.03820-14","article-title":"Inflammation is associated with voriconazole trough concentrations","volume":"58","author":"van Wanrooy","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcrc.2023.154395_bb0200","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s40262-022-01122-5","article-title":"Hyperinflammation reduces midazolam metabolism in critically ill adults with COVID-19","volume":"61","author":"Smeets","year":"2022","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jcrc.2023.154395_bb0205","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0009-9236(03)00066-3","article-title":"Effects of the neurokinin1 receptor antagonist aprepitant on the pharmacokinetics of dexamethasone and methylprednisolone","volume":"74","author":"McCrea","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jcrc.2023.154395_bb0210","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1177\/1078155218783248","article-title":"Significant drug interaction between voriconazole and dexamethasone: a case report","volume":"25","author":"Taghvaye Masoumi","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.jcrc.2023.154395_bb0215","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1001\/jama.1985.03360150038012","article-title":"Phenytoin-dexamethasone: a possible drug-drug interaction","volume":"254","author":"Wong","year":"1985","journal-title":"Jama"},{"key":"10.1016\/j.jcrc.2023.154395_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145665","article-title":"Inferring molecular mechanisms of dexamethasone therapy in severe COVID-19 from existing transcriptomic data","volume":"788","author":"Sharma","year":"2021","journal-title":"Gene"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944123001442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944123001442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:52:25Z","timestamp":1760125945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944123001442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":44,"alternative-id":["S0883944123001442"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2023.154395","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population pharmacokinetics of dexamethasone in critically ill COVID-19 patients: Does inflammation play a role?","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2023.154395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154395"}}